Vanguard Portfolio Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$223M Buy
4,836,979
+120,788
+3% +$5.82M 0.01% 1114
2026
Q2
$277M Buy
4,716,191
+271,461
+6% +$11.4M 0.01% 1033
2026
Q1
$143M Buy
+4,444,730
New +$165M 0.01% 1311

Other funds holding VCYT

Vanguard Portfolio Management's VCYT Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Veracyte (VCYT) stake by 2.6% in Q3 2026, buying an estimated $5.82M and bringing the position to 4,836,979 shares worth $223M. The position accounts for 0.01% of the portfolio, ranked #1114.

Vanguard Portfolio Management first reported a position in VCYT in Q1 2026 and has held it in 3 quarters since. The position peaked at $277M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Vanguard Portfolio Management held 4,836,979 shares of Veracyte worth $223M as of Q3 2026.
  • Vanguard Portfolio Management bought 120,788 Veracyte shares in Q3 2026, an estimated $5.82M.
  • Veracyte made up 0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1114 holding.
  • Vanguard Portfolio Management first reported a position in Veracyte in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Veracyte position peaked at $277M in Q2 2026.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.